Bausch&Lomb Envision TD
This article was originally published in The Gray Sheet
Executive Summary
Implantable drug delivery system development at firm's Waterford, Ireland facility is expected to yield an eye implant to treat posterior uveitis and diabetic macular edema, B&L announces Feb. 26. Late stage clinical trials using the drug fluocinolone acetonide in combination with the "rice-grain" sized delivery device for the indications in the U.S., Europe and Japan could lead to commercialization in 2004; FDA has granted the device "fast track" status, firm notes. Clinical trials for age-related macular degeneration began in January...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.